Sponsor:
Jazz Pharmaceuticals
Code:
NCT05734066
Conditions
Refractory Ewing Sarcoma
Relapsed Ewing Sarcoma
Ewing Sarcoma
Eligibility Criteria
Sex: All
Age: 2 - 30
Healthy Volunteers: Not accepted
Interventions
Lurbinectedin
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-19. This information was provided to ClinicalTrials.gov by Jazz Pharmaceuticals on 2025-01-23.